Why is Venus Remedies falling/rising?

As of 30-Jun, Venus Remedies Ltd's stock price is currently at 460.00, reflecting a rise of 1.0 (0.22%). The stock has shown a positive performance recently, gaining 6.75% over the last four days and is currently trading close to its 52-week high, just 3.22% away from Rs 474.8. Despite underperforming its sector by 0.47% today, the stock opened with a gain of 3.27% and reached an intraday high of Rs 474. The company has demonstrated strong financial health, with a low debt-to-equity ratio of 0.01 times and a significant net profit growth of 99.81%. Additionally, it has consistently delivered positive results over the last two quarters, contributing to its attractive valuation and a PEG ratio of 0.5, which suggests that the stock is fairly valued compared to its peers.
In the broader market context, Venus Remedies has outperformed the benchmark Sensex with a 1-week return of 6.24% compared to the Sensex's 2.09%, and a year-to-date return of 45.96% against the Sensex's 7.00%. This strong performance indicates that investor sentiment towards the stock remains positive, despite the lack of domestic mutual fund investment, which could suggest some caution among institutional investors. The rising investor participation, evidenced by a significant increase in delivery volume, further supports the stock's upward movement. Overall, the combination of strong financial results, consistent returns, and positive investor engagement contributes to the stock's rising price.